India faces the challenge of inappropriate use of antibiotics while Bharat copes with poor access to treatment, resulting in a policy conundrum and inaction. India was recently in the news for the wrong reasons. The serious threat posed by the newly discovered microbe, NDM-1 (New Delhi metallo--lactamase-1), resistant to many antibiotics, triggered alarm and panic. Predictions that the country will not meet the millennium development goal for child mortality caused dismay....
More »SEARCH RESULT
Consumer protection a neglected area: Activists
Experts and consumer activists have asked the Centre and the States to implement more effectively the provisions of the Consumer Protection Act, 1986 (COPRA) which they hailed as a strong and powerful legislation. The group, participating in a round-table of GRANIRCA (Grassroots Reachout and Networking in Rajasthan through Consumer Action) here, lamented that consumer protection remained a neglected area for the governments which failed to create the basic infrastructure for...
More »Illegal tiger trade 'killing 100 big cats each year' by Mark Kinver
The illegal trade in tiger parts has led to more than 1,000 wild tigers being killed over the past decade, a report suggests. Traffic International, a wildlife trade monitoring network, found that skins, bones and claws were among the most common items seized by officials. The trade continues unabated despite efforts to protect the cats, it warns. Over the past century, tiger numbers have fallen from about 100,000 individuals to just an estimated...
More »Drugs getting costlier, people cheaper by Harsimran Shergill
MONA SANGWAN, a teacher at a private school in Delhi, who earns just Rs. 4,000 a month and is her family’s sole earning member, had nearly begun to despair. How on earth was she going to raise Rs. 7,000 every month to buy the medicines her brother Ashwini, a kidney transplant patient, needed? Mona would have continued to despair had not the NGO Sarvohit Social Welfare Society stepped in. And to...
More »Foreign bias finger at PMO on cheap drugs
Multinational drug companies appear to have used the Prime Minister’s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said. In a joint letter to Prime Minister Manmohan Singh, 50 NGOs said the PMO had asked the ministry of health and the departments of legal affairs and industrial policy to examine intellectual property rights issues raised by foreign pharmaceutical...
More »